109 related articles for article (PubMed ID: 21778760)
1. Insulin-like growth factor I: pros and cons of a bioassay.
Janssen JA
Horm Res Paediatr; 2011; 76 Suppl 1():106-10. PubMed ID: 21778760
[TBL] [Abstract][Full Text] [Related]
2. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.
Brugts MP; Ranke MB; Hofland LJ; van der Wansem K; Weber K; Frystyk J; Lamberts SW; Janssen JA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2539-45. PubMed ID: 18397983
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the GH/IGF-axis components: lessons from human studies.
Frystyk J
Domest Anim Endocrinol; 2012 Aug; 43(2):186-97. PubMed ID: 22153974
[TBL] [Abstract][Full Text] [Related]
4. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
Chen JW; Ledet T; Orskov H; Jessen N; Lund S; Whittaker J; De Meyts P; Larsen MB; Christiansen JS; Frystyk J
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1149-55. PubMed ID: 12604504
[TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease.
Janssen JAMJL; Varewijck AJ; Brugts MP
Growth Horm IGF Res; 2019; 48-49():16-28. PubMed ID: 31493625
[TBL] [Abstract][Full Text] [Related]
6. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
[TBL] [Abstract][Full Text] [Related]
7. Kinase Receptor Activation (KIRA): a rapid and accurate alternative to endpoint bioassays.
Sadick MD
Dev Biol Stand; 1999; 97():121-33. PubMed ID: 10463538
[TBL] [Abstract][Full Text] [Related]
8. Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays.
Sadick MD; Intintoli A; Quarmby V; McCoy A; Canova-Davis E; Ling V
J Pharm Biomed Anal; 1999 May; 19(6):883-91. PubMed ID: 10698554
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls of insulin-like growth factor I assays.
Bidlingmaier M
Horm Res; 2009 Jan; 71 Suppl 1():30-3. PubMed ID: 19153502
[TBL] [Abstract][Full Text] [Related]
10. Acromegaly and serum insulin-like growth factor I.
Thorner MO
Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
[TBL] [Abstract][Full Text] [Related]
12. Circulating bioactive and immunoreactive IGF-I remain stable in women, despite physical fitness improvements after 8 weeks of resistance, aerobic, and combined exercise training.
Nindl BC; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Kraemer WJ; Maresh CM; Spiering BA; Hatfield DL; Flyvbjerg A; Frystyk J
J Appl Physiol (1985); 2010 Jul; 109(1):112-20. PubMed ID: 20395543
[TBL] [Abstract][Full Text] [Related]
13. Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality.
Brugts MP; van den Beld AW; Hofland LJ; van der Wansem K; van Koetsveld PM; Frystyk J; Lamberts SW; Janssen JA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2515-22. PubMed ID: 18413430
[TBL] [Abstract][Full Text] [Related]
14. Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients.
Brugts MP; Tjiong HL; Rietveld T; Wattimena JL; van den Berg JW; Fieren MW; Janssen JA
Nephrol Dial Transplant; 2010 Mar; 25(3):940-6. PubMed ID: 19903658
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
16. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
Grinspoon S; Clemmons D; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
[TBL] [Abstract][Full Text] [Related]
19. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
[TBL] [Abstract][Full Text] [Related]
20. Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs.
Okajima T; Nakamura K; Zhang H; Ling N; Tanabe T; Yasuda T; Rosenfeld RG
Endocrinology; 1992 Apr; 130(4):2201-212. PubMed ID: 1372238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
